Membranous lipodystrophy (Nasu-Hakola disease) presenting an unusually benign clinical course

Kumiko Haruta1, Shunji Matsunaga, Hiroshi Ito

  • 1Department of Orthopaedic Surgery, Faculty of Medicine, Kagoshima University 8-35-1, Sakuragaoka, Kagoshima 890-8520, Japan.

Oncology Reports
|June 7, 2003
PubMed

Insights

Nasu-Hakola disease, or membranous lipodystrophy, typically causes dementia. This case study highlights a patient with an unusually benign 16-year clinical course, showing no typical neuropsychiatric symptoms.

Area of Science:

  • Neurology
  • Genetics
  • Radiology

Background:

  • Membranous lipodystrophy, also known as Nasu-Hakola disease, is a rare genetic disorder.
  • Characterized by progressive presenile dementia, sclerosing leukoencephalopathy, and skeletal polycystic lesions.
  • Limited long-term follow-up data exists for patients with this condition.

Observation:

  • A 56-year-old female patient with membranous lipodystrophy was followed for 16 years post-treatment.
  • The patient underwent curettage and bone grafts for skeletal lesions.
  • Periodic examinations included imaging to monitor for disease progression.

Findings:

  • The patient exhibited an unusually benign clinical course, lacking typical neuropsychiatric symptoms.
  • No recurrence of skeletal lesions or development of new cystic lesions was observed over 16 years.
  • Brain imaging (CT and MRI) showed no abnormalities typically associated with Nasu-Hakola disease.

Implications:

  • Suggests that some individuals with membranous lipodystrophy may experience a less severe clinical trajectory.
  • Highlights the importance of long-term monitoring in rare genetic disorders.
  • Contributes to understanding the phenotypic variability of Nasu-Hakola disease.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...